Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
KUAISHOU-W
01024
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -4.28%14.21M | -11.96%10.01M | -8.70%14.67M | 54.43%64.01M | 47.68%21.73M | 30.82%14.85M | 36.18%11.36M | 128.23%16.07M | 38.69%41.45M | 61.65%14.71M |
| Cost of revenue | -15.35%5.95M | -21.54%3.49M | -22.24%8.16M | 89.32%32.81M | 70.94%10.85M | 59.33%7.03M | 35.83%4.44M | 217.72%10.49M | 43.15%17.33M | 88.00%6.35M |
| Gross profit | 5.66%8.26M | -5.81%6.52M | 16.75%6.52M | 29.36%31.2M | 30.03%10.88M | 12.70%7.82M | 36.40%6.92M | 49.25%5.58M | 35.66%24.12M | 46.11%8.37M |
| Operating expense | 2.46%5.84M | -0.84%5.56M | 7.30%5.72M | -5.20%25.38M | -30.95%8.24M | 17.12%5.7M | 15.46%5.61M | 4.00%5.33M | 38.06%26.77M | 111.03%11.93M |
| Selling and administrative expenses | 2.46%5.84M | -0.84%5.56M | 7.30%5.72M | -5.20%25.38M | -30.95%8.24M | 17.12%5.7M | 15.46%5.61M | 4.00%5.33M | 38.06%26.77M | 111.03%11.93M |
| -General and administrative expense | 2.46%5.84M | -0.84%5.56M | 7.30%5.72M | -5.20%25.38M | -30.95%8.24M | 17.12%5.7M | 15.46%5.61M | 4.00%5.33M | 38.06%26.77M | 111.03%11.93M |
| Operating profit | 14.28%2.43M | -27.04%958K | 214.96%800K | 319.15%5.82M | 174.07%2.64M | 2.31%2.12M | 505.07%1.31M | 118.37%254K | -64.55%-2.66M | -5,022.58%-3.56M |
| Net non-operating interest income (expenses) | 22.58%-24K | -17.39%-27K | -61.11%-29K | 63.32%-108.73K | 86.55%-37K | -287.50%-31K | -283.33%-23K | -157.14%-18K | -640.44%-296.44K | -3,322.53%-275K |
| Non-operating interest expense | -22.58%24K | 17.39%27K | 61.11%29K | -63.32%108.73K | -86.55%37K | 287.50%31K | 283.33%23K | 157.14%18K | 640.44%296.44K | 3,322.53%275K |
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | -86.99%32K | 122.84%37K | -114.39%-20K | 147.30%226.11K | -83.51%31K | 203.36%246K | 52.21%-162K | 256.18%139K | -600.71%-478.06K | 11.59%188K |
| Special income (charges) | -150.00%-3K | 115.12%75K | -15.09%-61K | -1,827.12%-97.49K | -150.00%-65K | 200.00%6K | -3,642.86%-496K | -507.69%-53K | -125.76%-5.06K | -256.27%-26K |
| Less:Write off | 150.00%3K | -115.12%-75K | 15.09%61K | 1,827.12%97.49K | 150.00%65K | -200.00%-6K | 3,642.86%496K | 507.69%53K | 125.76%5.06K | 256.27%26K |
| Other non-operating income (expenses) | -77.52%158K | 136.67%142K | 22.15%182K | -57.06%1.57M | -67.10%654K | 127.51%703K | -94.94%60K | -9.70%149K | 435.84%3.65M | 2,251.33%1.99M |
| Income before tax | -15.04%2.59M | 71.24%1.19M | 85.14%872K | 3,394.68%7.4M | 290.82%3.22M | 42.94%3.05M | -35.39%692K | 136.20%471K | 124.70%211.88K | -605.64%-1.69M |
| Income tax | 49.77%638K | 46.26%724K | 30.86%318K | 97.37%2.34M | 115.06%1.16M | 20.68%426K | 153.85%495K | 147.96%243K | 26.06%1.18M | 139.74%538K |
| Net income | -25.57%1.95M | 134.01%461K | 142.98%554K | 621.16%5.07M | 192.77%2.07M | 47.36%2.62M | -77.51%197K | 116.30%228K | 45.90%-972.32K | -2,131.60%-2.23M |
| Net income continuous operations | -25.57%1.95M | 134.01%461K | 142.98%554K | 621.16%5.07M | 192.77%2.07M | 47.36%2.62M | -77.51%197K | 116.30%228K | 45.90%-972.32K | -2,131.60%-2.23M |
| Noncontrolling interests | -80.00%5K | 33.33%-4K | 58.33%-5K | 101.06%866 | 94.74%-2K | 327.27%25K | 70.00%-6K | 7.69%-12K | -10.33%-81.74K | 11.80%-38K |
| Net income attributable to the company | -25.05%1.95M | 129.06%465K | 132.92%559K | 668.90%5.07M | 194.47%2.07M | 45.05%2.6M | -77.34%203K | 117.32%240K | 48.32%-890.59K | -1,533.52%-2.19M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -25.05%1.95M | 129.06%465K | 132.92%559K | 668.90%5.07M | 194.47%2.07M | 45.05%2.6M | -77.34%203K | 117.32%240K | 48.32%-890.59K | -1,533.52%-2.19M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -24.44%0.0034 | 100.00%0.0008 | 150.00%0.001 | 686.67%0.0088 | 194.74%0.0036 | 45.16%0.0045 | -75.00%0.0004 | 116.67%0.0004 | 50.00%-0.0015 | -1,366.67%-0.0038 |
| Diluted earnings per share | -24.44%0.0034 | 100.00%0.0008 | 150.00%0.001 | 686.67%0.0088 | 194.74%0.0036 | 45.16%0.0045 | -75.00%0.0004 | 116.67%0.0004 | 50.00%-0.0015 | -1,366.67%-0.0038 |
| Dividend per share | ||||||||||
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.